Pulmonary embolism Trials in Saint-Étienne, France
Conditions / Pulmonary embolism / Saint-Étienne, France
Research into Pulmonary embolism spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04657120 | Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy | COMPLETED | NA |
| NCT06386107 | Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis | RECRUITING | NA |
| NCT00423319 | Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) | COMPLETED | PHASE3 |
| NCT05171075 | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | TERMINATED | — |
| NCT05171049 | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | TERMINATED | PHASE3 |
| NCT00439777 | Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study | COMPLETED | PHASE3 |
| NCT02923115 | Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism | COMPLETED | PHASE1/PHASE2 |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT00457002 | Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness | COMPLETED | PHASE3 |
| NCT04430569 | Pulmonary Embolism International THrOmbolysis Study-3 | RECRUITING | PHASE3 |